| 1 |
34294186 | Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry. | 2022 Apr |
1 |
| 2 |
34645988 | Urinary albumin-to-creatinine ratio and the risk of first stroke in Chinese hypertensive patients treated with angiotensin-converting enzyme inhibitors. | 2022 Jan |
1 |
| 3 |
33973994 | Levels of angiotensin-converting enzyme 1 and 2 in serum and urine of children with Sickle Cell Disease. | 2021 Jul-Sep |
1 |
| 4 |
31303349 | Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction. | 2020 Jan |
2 |
| 5 |
32226931 | Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy. | 2020 Mar |
1 |
| 6 |
32981368 | Association of Albuminuria Levels With the Prescription of Renin-Angiotensin System Blockade. | 2020 Dec |
4 |
| 7 |
30571562 | Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus. | 2019 Jan |
3 |
| 8 |
31144454 | Simultaneous quantification of urinary purines and creatinine by ultra high performance liquid chromatography with ultraviolet spectroscopy and quadrupole time-of-flight mass spectrometry: Method development, validation, and application to gout study. | 2019 Aug |
1 |
| 9 |
31719297 | Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia. | 2019 Sep |
3 |
| 10 |
29794446 | Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis. | 2018 |
2 |
| 11 |
27269276 | Lisinopril-Induced Alopecia: A Case Report. | 2017 Oct |
1 |
| 12 |
28344754 | Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. | 2017 Mar 15 |
2 |
| 13 |
27546928 | Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease. | 2016 Jun 30 |
1 |
| 14 |
25878372 | A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy. | 2015 Mar-Apr |
2 |
| 15 |
26000752 | Association between Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism and Prognosis of Kidney Transplantation: A Meta-Analysis. | 2015 |
1 |
| 16 |
24362637 | Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients. | 2014 Jun |
1 |
| 17 |
25232564 | Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study. | 2014 |
2 |
| 18 |
22739771 | Genetic variation in the renin-angiotensin-aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease. | 2013 Apr |
1 |
| 19 |
24157497 | Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis. | 2013 Oct 24 |
1 |
| 20 |
26105881 | PP025. Measurement of the activity of the circulating and intrarenal renin-angiotensin system (iRAS) in pregnant and non-pregnant subjects. | 2013 Apr |
1 |
| 21 |
21976404 | Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus. | 2012 Jan |
1 |
| 22 |
22982912 | Expression of angiotensin-converting enzyme mRNA gene in the kidneys of patients with glomerulonephrites. | 2012 Sep |
1 |
| 23 |
21317676 | Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. | 2011 Sep |
1 |
| 24 |
22783291 | Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population. | 2011 Jun |
1 |
| 25 |
20104936 | ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized? | 2010 Feb 1 |
1 |
| 26 |
21103678 | Temporal trends in acute renal dysfunction among critically ill patients according to I/D and -262A > T ACE polymorphisms. | 2010 Apr-Jun |
1 |
| 27 |
23148146 | Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient. | 2010 Feb |
1 |
| 28 |
18068386 | French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. | 2008 Feb |
1 |
| 29 |
18284535 | The D allele of angiotensin-converting enzyme polymorphism as a predictor of renal function decline over 4 years in an apparently healthy Chinese population aged 60 and older. | 2008 Apr |
1 |
| 30 |
18371537 | Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. | 2008 Apr |
1 |
| 31 |
17903694 | Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy. | 2007 Oct |
1 |
| 32 |
18035185 | Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? | 2007 Sep |
1 |
| 33 |
16544182 | Bone marrow transplant nephropathy successfully treated with angiotensin-converting enzyme inhibitor. | 2006 Mar |
1 |
| 34 |
16685140 | Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. | 2006 |
1 |
| 35 |
17066218 | Management of heart failure in the elderly: recommendations from the French Society of Cardiology (SFC) and the French Society of Gerontology and Geriatrics (SFGG). | 2006 Sep-Oct |
1 |
| 36 |
17699280 | Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors. | 2006 Jul |
1 |
| 37 |
15848522 | The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney. | 2005 Mar |
1 |
| 38 |
16078597 | [Possibilities of outpatient renoprotective therapy]. | 2005 |
1 |
| 39 |
16194413 | [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?]. | 2005 Aug |
1 |
| 40 |
16245436 | [Predictors of successful renal artery revascularization in atherosclerotic renovascular disease]. | 2005 Aug |
1 |
| 41 |
16338452 | Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. | 2005 Dec 10 |
1 |
| 42 |
16362602 | Detection of occult renovascular disease in unexplained chronic kidney disease. | 2005 |
1 |
| 43 |
14673630 | ACE inhibition in the treatment of children after renal transplantation. | 2004 Feb |
1 |
| 44 |
15017529 | Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues. | 2004 Mar |
2 |
| 45 |
15168387 | The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. | 2004 Jun |
1 |
| 46 |
15198481 | Angiotensin-converting enzyme inhibitor usage in patients with incidental atherosclerotic renal artery stenosis. | 2004 May |
1 |
| 47 |
15289383 | National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. | 2004 Aug 10 |
1 |
| 48 |
15369420 | Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control. | 2004 Sep |
1 |
| 49 |
15482412 | An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. | 2004 Nov |
1 |
| 50 |
15489090 | The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. | 2004 Oct 19 |
1 |